RNS Number : 6076N Poolbeg Pharma PLC 23 July 2026 TR-1: Standard form for notification of major holdingsThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United…
RNS Number : 1130N Poolbeg Pharma PLC 21 July 2026 Poolbeg Pharma plcNotice of Allowance received for POLB 001 Cancer Immunotherapy-induced CRS patent in IsraelContinued momentum in Poolbeg's global intellectual property strategy21 July 2026 - Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Compan…
RNS Number : 9707L Poolbeg Pharma PLC 13 July 2026 Poolbeg Pharma plcFirst Patient Dosed in the POLB 001 TOPICAL Clinical TrialInterim data remains on track for summer 2026 and partnering discussions continue to advance with multiple companiesHighlights· First patient dosed in the POLB 001 T…
